|
|
|
American Society of Interventional Pain Physicians News | August 19, 2015
|
|
|
|  Register today for Ultrasound for Regenerative Medicine and Cadaver Workshop in Memphis
ASIPP's Ultrasound for Regenerative Medicine Workshop is scheduled for
September 18, 2015 and the Hands-on Cadaver Workshop for IPM Techniques, September 19 - September 20, 2015 Objectives for this Intensive Ultrasound for Regenerative Medicine Workshop are:
- Attain the ability to understand ultrasound interpretation and regenerative medicine.
- To incorporate ultrasound and regenerative medicine in treating your patients so that patients have better outcomes and reduced side effects.
- mprove existing skills and/or develop new skills in the delivery of interventional techniques involving ultrasound and regenerative medicine.
- Ability to demonstrate skills.
Cadaver Workshop Objectives:
- To integrate multiple aspects of interventional pain management in treating your patients so that patients have better outcomes and reduced side effects.
- Provide high-quality, competent, safe, accessible, and cost-efficient services to your patients.
- Improve existing skills and/or develop new skills in the delivery of interventional techniques.
- Review multiple areas of interventional pain management including fluoroscopic interpretation and radiation safety.
- Demonstrate skills through interactive review of images.
 Accommodations The Westin Memphis Beale Street Hotel 170 Lt. George W. Lee Avenue · Memphis, TN, 38103 | 901-334-5900 We have secured a group room rate of $129. Reserve rooms early-all unbooked rooms will be released after September 3, 2015. Click HERE for link to hotel Register: http://www.asipp.org/0915-registration.htm |
 ASIPP to hold ICD-10-CM Comprehensive and ICD-9-CM to ICD-10-CM
The focus of this two-part webinar will be on ICD-10-CM Comprehensive and ICD-9-CM to ICD-10-CM coding crosswalks and necessary documentation!
The webinar will be in two parts: Part 1 will cover chapters 1-10 and Part 2 will cover chapters 11-21.
Part 1: Thursday, September 3
11am CDT - 12:30pm CDT
Part 2: Thursday, September 10 a
11am CDT - 12:30pm CDT
WEBINAR FEE:
$195
SPEAKER:
Marvel Hammer, RN, CPC ,
MJH Consulting, Denver, Colorado
There will be time for Q&A with the presenter.
* This program has the approval of the American Academy of Professional Coders (AAPC) for 3 continuing education hours.Granting of prior approval in no way constitutes endorsement by the AAPC of the program content or the program sponsor.
|
ASIPP 2016 Annual Meeting To Feature Key Note Speaker: Robert Laszewski
Robert Laszewski , president of Health Policy and Strategy Associates, Inc. (HPSA), is scheduled to be Key-Note speaker at the AsIPP 18th annual meeting this April in Dallas.
Bob Laszewski was named the Washington Post's Wonkblog "Pundit of the Year" for 2013 for "one of the most accurate and public accounts" detailing the first few months of the Obamacare rollout.
Below are links to Articles from our keynote speaker for the Annual Meeting
Has Obamacare Really Reduced The Uninsured By 16 Million And Continued To Show Strong Growth?
Registration for the Annual Meeting should be open next week.
|
Major publisher retracts 64 scientific papers in fake peer review outbreak
Made-up identities assigned to fake e-mail addresses. Real identities stolen for fraudulent reviews. Study authors who write glowing reviews of their own research, then pass them off as an independent report.
These are the tactics of peer review manipulators, an apparently growing problem in the world of academic publishing.
Peer review is supposed to be the pride of the rigorous academic publishing process. Journals get every paper reviewed and approved by experts in the field, ensuring that problematic research doesn't make it to print.
|
Manchikanti: Florida Pill Mill Law Has Achieved its Goals
Overall, this manuscript may provide reasonably accurate data, but it is misleading. It simply concludes that Florida Prescription Drug Monitoring Program (PDMP) and pill mill laws were associated with modest decrease in opioid prescribing and use; however, it misses multiple issues which are eluded in the manuscript itself that abolishing pill mills, reducing deaths, and reducing overall prescription use, overuse, and abuse. Consequently, the title should be that despite prescription drug monitoring program and pill mill laws, patients receive appropriate opioids.
Click Here to read story:
Florida legislation aimed at opioid abuse tied to dip in prescriptions
|
Study fuels push for FDA e-cigarette regulation
As the healthcare and retail industries await federal regulation on electronic cigarettes, a new JAMA study has found that young e-smokers are more likely to try tobacco than those who have never "vaped."
In 2013, researchers with Keck School of Medicine at the University of Southern California at Los Angeles surveyed 2,530 ninth-graders from 10 Los Angeles-area high schools who said they had never smoked tobacco. But 222 students in this group of mostly 14-year-olds did report trying e-cigarettes. When surveyed six and then 12 months later, the adolescents that had previously vaped were more likely to have tried smoking tobacco.
In the first follow up, 31% of those who admitted using e-cigarettes in the original survey said they had subsequently tried smoking tobacco compared with 8% in the group that had never used e-cigarettes. After 12 months, 25% of the e-smoking group said they had smoked tobacco in the past six months compared with 9% in the non-e-smoking group.
See Related Story:
|
White House Drug Policy Office Funds New Projects in High Intensity Drug Trafficking Areas
Funds will target heroin trafficking and support prevention efforts
Washington
, D.C.
- Today, Michael Botticelli, Director of National Drug Control Policy, announced $13.4 million in funding for High Intensity Drug Trafficking Areas (HIDTA). Of that, $5 million will be directed to a broad range of efforts that will reduce the trafficking, distribution, and use of heroin - a drug that has emerged as a serious threat to multiple regions of the United States.
In particular, $2.5 million will fund the Heroin Response Strategy, an unprecedented partnership among five regional HIDTA programs - Appalachia, New England, Philadelphia/Camden, New York/New Jersey, and Washington/Baltimore - to address the severe heroin threat facing those communities through public health-public safety partnerships across 15 states.
|
FTC issues first-ever guidelines on unfair competition
T
he U.S. Federal Trade Commission released long-awaited guidance Thursday on a section of business antitrust law that bars unfair competition - a topic that has received significant attention in the healthcare sector.
The FTC's policy statement outlines the basic principles the commission will use when deciding whether to go after businesses for unfair competition under Section 5 of the 1914 FTC Act, which says "unfair methods of competition in or affecting commerce" are illegal. In the more than 100 years since the FTC Act was enacted, the FTC has never formally defined what it means for a business to compete unfairly, according to the Wall Street Journal.
Below are the three new principles the FTC outlined:
- The commission will be guided by the public policy underlying the antitrust laws, namely, the promotion of consumer welfare;
- The act or practice will be evaluated under a framework similar to the rule of reason, that is, an act or practice challenged by the commission must cause, or be likely to cause, harm to competition or the competitive process, taking into account any associated cognizable efficiencies and business justifications; and
- The commission is less likely to challenge an act or practice as an unfair method of competition on a standalone basis if enforcement of the Sherman or Clayton Act is sufficient to address the competitive harm arising from the act or practice.
|
FDA Approves OxyContin for Kids as Young as 11
 The U.S. Food and Drug Administration said it has approved the use of the painkiller OxyContin in children as young as 11, for severe pain that can't be adequately treated with other medications.
An FDA spokesman said the agency granted the approval Thursday, after the drug's manufacturer, Purdue Pharma LP, submitted clinical-trial data on the drug's safety and efficacy in children. In a posting on its website, the FDA said it asked Purdue to perform the studies in children.
OxyContin is an extended-release version of oxycodone, a powerful opioid painkiller. Widespread use of opioids in recent decades has helped spark what public-health officials call an epidemic of painkiller abuse in the U.S., including soaring rates of overdose deaths.
|
Chronic Low Back Pain: Pregabalin Helps Reduce Pain and Sleep Interference
A new study suggests that pregabalin shows significantly greater improvements in pain-related interference of sleep relative to usual care in patients with chronic low back pain with accompanying neuropathic pain (CLBP-NeP).
Sleep disturbance is particularly important for CLBP-NeP patients. Earlier studies have shown that patients reported significantly greater sleep disturbance and impairment of quality of life at higher pain severity levels. In Japan, nearly 30% of patients with CLBP have a NeP component. Sleep disturbance is one of the most prevalent coexisting conditions in patients with CLBP-NeP. This presents a significant challenge for treatment, because many standard analgesics - including acetaminophen and NSAIDS - have generally poor efficacy for NeP. -
|
Man in NY poses as physician for 3 years before being caught
A man in New York has been arrested and accused of posing as a medical doctor and clinical psychologist for three years, according to a CNN report.
Despite never completing any medical school or doctoral program, Donald Lee-Edwards' letterhead indicates he has earned the titles of PhD, MD, LP and clinical psychologist.
Mr. Lee-Edwards caught the attention of the Richmond County District Attorney's Office in June, after patients complained of his unorthodox bedside manner and prescription practices, according to the report.
|
|
|
|
|
|
State Society News
Save The Date! CASIPP Meeting set for October 2015
The California chapter of the American Society of Interventional Pain Physicians
will hold its 6th Annual Meeting in Monterey, CA at the Monterey Plaza Hotel Resort over the weekend of October 16-18. Agenda and registration can be found online at
www.casipp.com
or by calling 661-435-3473.
NY and NJ Societies to hold Pain Symposium Nov. 5-8
The New York and New Jersey Societies of Interventional Pain Physicians will host a Pain Symposium titled Evolving Pain Therapies on November 5-8, 2015 at the Hyatt Regency, Jersey City, NJ. Click HERE for Schedule and more information.
SAVE the DATE: FSIPP Meeting May 20-22, 2016
The Florida Society of Interventional Pain Physicians will hold its annual meeting in 2016 on May 20-22. The meeting will be held at the Orlando World Center Marriott in Orlando.
Watch FSIPP.org for more details.
FSIPP Releases Summer Newsletter
FSIPP has just published its Summer 2015 newsletter. The newsletter features highlights of the joint ASIPP/FSIPP meeting and articles such as: Collections, Connections and Corrections, Medical Marijuana, and Superficial Radial Nerve Entrapment.
Click HERE to read.
|
|
Physicians Wanted To view or post a job, please go to: http://jobs.asipp.org/home To receive a member discount for posting a job, use member code: 20Member |
|
|
